Pharmaceutical - Asia-Pacific, Management


Current filters:


Popular Filters

SillaJen changes its name to mark Jennerex acquisition


South Korean privately held pharma company SillaJen has changed its name to SillaJen Biotherapeutics…

Asia-PacificJennerexManagementMergers & AcquisitionsOncologyPexa-VecPharmaceuticalSillaJen

Takeda re-aligns marketing system in Japan


Japan’s largest drugmaker Takeda Pharmaceutical says it decided to re-align its marketing system in…

Asia-PacificJapanManagementMarkets & MarketingPharmaceuticalTakeda Pharmaceuticals

2014: A new dawn for pharma?

2014: A new dawn for pharma?


We take a look at the week's top stories.

Asia-PacificManagementNovartisPharmaceuticalTeva Pharmaceutical IndustriesUK

Should patients appreciate pharma?

Should patients appreciate pharma?


Here's our take on the week's top stories.


Report 3: Growth strategies in Japan’s pharma market – People - P Reed Maurer

Report 3: Growth strategies in Japan’s pharma market – People - P Reed Maurer


It is the people that set the Pharma industry apart from other industries. In one company you have an…


Eisai’s R&D organization undergoes “transformation”

Eisai’s R&D organization undergoes “transformation”


Japanese drugmaker Eisai's president and chief executive, Haruo Naito, says that the company's R&D organization,…

Asia-PacificEisaiEuropeManagementNorth AmericaPharmaceuticalResearchUSA

Japan market entry challenges – by P Reed Maurer

Japan market entry challenges – by P Reed Maurer


Not long ago, the last word in the title would have been obstacles rather than challenges, says P Reed…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Home Offices still don’t get Japan - by P Reed Maurer

Home Offices still don’t get Japan - by P Reed Maurer


Many, fortunately not all, senior managers of foreign pharma companies in Japan constantly struggle with…


Ono sets up subsidiary in South Korea


Japanese drugmaker Ono Pharmaceutical has decided to establish a new fully owned subsidiary in South…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Australia's PM-elect names health portfolio, but with a surprise


As has been largely expected, Australia's Prime Minister-elect Tony Abbott has this morning appointed…


GlaxoSmithKline could be considering quitting China, says BBC editor


For most multinational companies, it is a no-brainer that they have to be big in China, if their global…

Asia-PacificGlaxoSmithKlineLegalManagementMarkets & MarketingPharmaceutical

Most admired Pharma companies in Japan, by P Reed Maurer


For 14 years International Alliances Limited (IAL), headed by P Reed Maurer, has conducted an annual…


Succeeding in Japan's pharma market - by P Reed Maurer


It appears some Western pharma executives and their consultants cannot grasp the reality of Japan's pharma…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Daiichi Sankyo and Ranbaxy combine business operations in Thailand


Japanese pharma major Daiichi Sankyo (TYO: 4568) and its 64%-owned affiliate Ranbaxy Laboratories (AB:…

Asia-PacificDaiichi SankyoGenericsManagementMarkets & MarketingPharmaceuticalRanbaxy Laboratories

Winners in Japan's Pharma market, by P Reed Maurer


The difference between winning or losing in Japan's pharma market has enormous strategic implications…

Asia-PacificManagementMarkets & MarketingPharmaceuticalResearch

Japan's vulnerable pharma companies, by P Reed Maurer


Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

Most admired pharma companies in Japan, by IAL


Since 1999 International Alliances Limited (IAL), headed by P Reed Maurer, has conducted an annual survey…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Australian Health Minister replaced


Australian Prime Minister Julia Gillard on Monday reshuffled her cabinet to bring in "fresh blood" after…


AstraZeneca expands in China, cuts back in USA


It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

Back to top